Month: February 2025

MIAMI, Feb. 04, 2025 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (Cboe CA: JET, Cboe CA: JET.B, OTCQB: JETMF) (the “Company” or “GlobalX”), the Nation’s fastest growing charter airline, today announced that it expects to report fourth quarter and full year financial results that are at the high end of its previously issued 2024 guidance. The Company is also providing recent operational updates. The guidance below was provided in the Company’s third quarter 2024 earnings press release issued on November 6, 2024. These figures are presented in United States dollars and prepared in accordance with U.S. GAAP and are unaudited, unless otherwise noted. Financial Outlook  Q4 2024 FY 2024Revenue $55M – $61M $218M – $224M     Year-Over-Year Growth 2% – 13% 34% – 40%EBITDAR* $16M –...

COLUMBUS, Ohio, Feb. 04, 2025 (GLOBE NEWSWIRE) — Bread Financial® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending and saving solutions to millions of U.S consumers, today announced the company’s participation in the BofA Securities 2025 Financial Services Conference on Tuesday, Feb. 11. Bread Financial Chief Financial Officer Perry Beberman will participate in a fireside chat. The fireside chat will take place at 3:30 p.m. ET and will be broadcast live here. The fireside chat can also be accessed through Bread Financial’s investor relations website. A replay of the webcast will be available for 90 days following the event. About Bread Financial® Bread Financial® (NYSE: BFH) is a tech-forward financial services company that provides simple, personalized payment,...

BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, President and Chief Executive Officer, will present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference, being held virtually, on Tuesday, February 11, 2025 at 10:40 a.m. ET.   A webcast of Sensei’s presentation will be available in the Investors section of the Sensei website. A replay of the webcast will be on the website for approximately 90 days following the event. Registration for the webcast is available here. About Sensei Biotherapeutics  Sensei Biotherapeutics (Nasdaq: SNSE) is a clinical stage biotechnology company focused on the discovery and development of...

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) — I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s management team will participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference, being held virtually, on February 11-12, 2025. Details are as follows:Oppenheimer’s 35th Annual Healthcare Life Sciences ConferenceConference Date:   February 11-12, 2025Format:   Company Presentation and one-on-one meetingsPresentation Time:   Tuesday, February 11, 2025, 4:00 to 4:30 PM ETWebcast Link:   https://wsw.com/webcast/oppenheimer39/imab/2739496 About I-Mab I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, focused on the development of precision immuno-oncology...

EMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the Oppenheimer 35th Annual Healthcare Life Sciences Conference being held virtually, February 11-12, 2025. Owen Hughes, Chief Executive Officer, and Brad Sitko, Chief Investment Officer, will participate in a fireside chat on Tuesday, February 11, 2025 at 3:20 PM ET. The presentation can be assessed by visiting https://bit.ly/4jAMqQw. XOMA’s presentations can also be accessed by visiting the investor relations section of the Company’s website at www.xoma.com.  A replay of each presentation will be available and archived on the site for 90 days after the event. About XOMA Royalty CorporationXOMA Royalty is a biotechnology royalty aggregator...

Shelton, CT, Feb. 04, 2025 (GLOBE NEWSWIRE) — HUBBELL REPORTS FOURTH QUARTER 2024 AND FULL YEAR RESULTSQ4 diluted EPS of $3.64; adjusted diluted EPS of $4.10 (up 11% y/y) Q4 net sales -1% (organic -3%; net M&A +3%) Q4 operating margin 19.3%; adjusted operating margin 21.8% (up 240bps y/y) FY 2024 diluted EPS of $14.37; adjusted diluted EPS of $16.57 FY 2025 diluted EPS expected range of $16.00-$16.50; adj. diluted EPS of $17.35-$17.85SHELTON, CT. (February 4, 2025) – Hubbell Incorporated (NYSE: HUBB) today reported operating results for the fourth quarter and full year ended December 31, 2024. “Hubbell delivered double-digit growth in operating profit, earnings per share and free cash flow in the fourth quarter” said Gerben Bakker, Chairman, President and CEO. “While organic growth was below our expectations in...